Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of LBH589 (Panobinostat) in Adult Patients With Recurrent Malignant Gliomas

NCT00848523 is registered in ClinicalTrials.gov with Neurological Surgery, P.C. as lead sponsor.

NCT NCT00848523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00848523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of LBH589 (Panobinostat) in Adult Patients With Recurrent Malignant Gliomas
Lead sponsor
Neurological Surgery, P.C.
Phase
Phase 2
Overall status
Terminated
Start date
November 30, 2008
Completion date
April 30, 2009
Enrollment
6 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent malignant gliomas